Search
Displaying 381–390 of 726 for “retinal diseases”
-
Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval
Research NewsOne-time injection could treat RP patients regardless of underlying genetic mutation
-
First patient treated with potential retinitis pigmentosa treatment from Sumitomo Pharma America
Research NewsCell therapy DSP-3077 is in Phase 1/2a clinical trials
-
Research News
First patient treated in Part B of ASTRA trial evaluating SB-007.
-
Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease
Research NewsThe Foundation funded preclinical studies for the approach and launched Opus.
-
SparingVision Launches Clinical Trial for Therapy to Re-Activate Dormant Cones in Advanced RP
Research NewsThe approach may provide better visual acuity than current optogenetic therapies in clinical trials.
-
Connecting and Empowering the Stargardt Community
The Foundation Fighting Blindness, with support from Alkeus Pharmaceuticals and Belite Bio, is creating a dedicated space for the Stargardt community—offering year-round opportunities to learn, connect, and share.
-
Nanoscope Begins Rolling BLA Submission to FDA for Seeking Approval for its Optogenetic Therapy
Research NewsThe company plans to complete BLA submission in early 2026.
-
Scientific Advisory Board Resources
SAB members should use this site to access reviewer resources, directory, and stay informed on SAB policies and events.
-
Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy
Research NewsThe Foundation is a founding investor in Atsena.
-
BlueRock’s Photoreceptor Cell Therapy to Move into Clinical Trial
Research NewsThe Foundation funded Dr. David Gamm for development of the induced pluripotent stem cell approach to be used in the trial.
.png)
